Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Scott

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Breast Cancer Research and Treatment|May 2, 2015
Incidental radiation to uninvolved internal mammary lymph nodes in breast cancerDivya Arora, Jessica Frakes, Jacob Scott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
YIA26-001: Collateral Sensitivities Emerge During the Evolution of Chemoresistance to Map Chemotherapy in OsteosarcomaZachary Burke, Gabe Mandel, Elizabeth Nowak, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 14, 2003
Inhibition of gap junctional intercellular communication by noncoplanar polychlorinated biphenyls: inhibitory potencies and screening for potential mode(s) of actionMiroslav Machala, Ludek Bláha, Jan Vondrácek, et al.
Plos Computational Biology|October 2, 2024
Quantitative evaluation of DNA damage repair dynamics to elucidate predictors of autism vs. cancer in individuals with germline PTEN variantsRuipeng Wei, Masahiro Hitomi, Tammy Sadler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
YIA26-001: Collateral Sensitivities Emerge During the Evolution of Chemoresistance to Map Chemotherapy in OsteosarcomaZachary Burke, Gabe Mandel, Elizabeth Nowak, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 1, 2026
CLO26-123: Genomic Adjusted Radiation Dose (GARD) Predicts Optimal Radiation Dose for Overall Survival in Triple-Negative Breast CancerShivani Nellore, Emily Ho, Nikhil Joshi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-123: Genomic Adjusted Radiation Dose (GARD) Predicts Optimal Radiation Dose for Overall Survival in Triple-Negative Breast CancerShivani Nellore, Emily Ho, Nikhil Joshi, et al.
International Journal of Neonatal Screening|December 29, 2020
At-Risk Testing for Pompe Disease Using Dried Blood Spots: Lessons Learned for Newborn ScreeningZoltan Lukacs, Petra Oliva, Paulina Nieves Cobos, et al.
ESMO Open|April 19, 2020
223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapyPete M Anderson, Jacob Scott, Shireen Parsai, et al.
Neuro-Oncology|November 16, 2014
Response to "Tumor cells in search for glutamate: an alternative explanation for increased invasiveness of IDH1 mutant gliomas"Andrew Trister, Jacob Scott, Russell Rockne, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|May 2, 2015
Incidental radiation to uninvolved internal mammary lymph nodes in breast cancerDivya Arora, Jessica Frakes, Jacob Scott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
YIA26-001: Collateral Sensitivities Emerge During the Evolution of Chemoresistance to Map Chemotherapy in OsteosarcomaZachary Burke, Gabe Mandel, Elizabeth Nowak, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 14, 2003
Inhibition of gap junctional intercellular communication by noncoplanar polychlorinated biphenyls: inhibitory potencies and screening for potential mode(s) of actionMiroslav Machala, Ludek Bláha, Jan Vondrácek, et al.
Plos Computational Biology|October 2, 2024
Quantitative evaluation of DNA damage repair dynamics to elucidate predictors of autism vs. cancer in individuals with germline PTEN variantsRuipeng Wei, Masahiro Hitomi, Tammy Sadler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
YIA26-001: Collateral Sensitivities Emerge During the Evolution of Chemoresistance to Map Chemotherapy in OsteosarcomaZachary Burke, Gabe Mandel, Elizabeth Nowak, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 1, 2026
CLO26-123: Genomic Adjusted Radiation Dose (GARD) Predicts Optimal Radiation Dose for Overall Survival in Triple-Negative Breast CancerShivani Nellore, Emily Ho, Nikhil Joshi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-123: Genomic Adjusted Radiation Dose (GARD) Predicts Optimal Radiation Dose for Overall Survival in Triple-Negative Breast CancerShivani Nellore, Emily Ho, Nikhil Joshi, et al.
International Journal of Neonatal Screening|December 29, 2020
At-Risk Testing for Pompe Disease Using Dried Blood Spots: Lessons Learned for Newborn ScreeningZoltan Lukacs, Petra Oliva, Paulina Nieves Cobos, et al.
ESMO Open|April 19, 2020
223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapyPete M Anderson, Jacob Scott, Shireen Parsai, et al.
Neuro-Oncology|November 16, 2014
Response to "Tumor cells in search for glutamate: an alternative explanation for increased invasiveness of IDH1 mutant gliomas"Andrew Trister, Jacob Scott, Russell Rockne, et al.
Pageof 6